Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0001562180-17-003378

Options or other derivatives

  • Chief Financial Officer acquired 61,511 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Hippel James Chief Financial Officer 2017-10-26 Grant or award · Restricted Stock Unit +4,438 4,438 D
Hippel James Chief Financial Officer 2017-10-26 Grant or award · Stock Options (Right to buy) +24,460 24,460 D
Hippel James Chief Financial Officer 2017-10-26 Grant or award · Stock Options (Right to buy) +32,613 32,613 D
Loading xslF345X03/primarydocument.xml…